Clinical Trial

IgniteData Appoints Dr. Jose Galvez as Chief Medical Information Officer to Accelerate Clinical Data Innovation

NEW CASTLE, Del., April 17, 2025 /PRNewswire/ -- IgniteData, the leader in eSource to sponsor interoperability for clinical research, is…

8 months ago

Advarra Integrates Study Startup and IRB Technologies, Enabling Unprecedented Visibility into Clinical Trial Site Activation

New Release of Advarra's Study Collaboration Solution Provides Sponsors and CROs a Single View into the Progress of Site Activation…

8 months ago

NMN Supplement: Best NMN Supplements To Boost NAD From Genuine Purity Liposomal NMN

Genuine Purity Liposomal NMN is renowned for its exceptional purity and efficacy in boosting NAD+ levels, crucial for DNA repair…

8 months ago

Following FDA Compassionate Use Approval for Pancreatic Carcinoma with Can-Fite’s Namodenoson, Leading U.S. Medical Centers Seek Authorization for their Patients

Ramat Gan, Israel, April 17, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company…

8 months ago

Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.

Sol-Gel to receive $16 million during 2025Cash runway is expected to extend into the first quarter of 2027; Company expects…

8 months ago

COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology

Strategic Collaboration Enhances Access to Cutting-Edge AI, Blockchain Solutions, Biopharma & Defense TechnologiesWEXFORD, Pa., April 17, 2025 (GLOBE NEWSWIRE) --…

8 months ago

Cardarine GW501516 SARMs: Cardarine Before & After Results, Benefits, Side Effects & Dosage – Buy Legal CrazyBulk Supplement

Cardarine GW501516 for sale. Is Cardarine Supplement Legal? Read This CrazyBulk CrazyBulk Albany, New York, April 17, 2025 (GLOBE NEWSWIRE)…

8 months ago

Moleculin Announces Acceptance of Abstract to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025

HOUSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company…

8 months ago

Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer

WATERTOWN, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical…

8 months ago

Actuate to Present Promising Data on Elraglusib in Advanced Salivary Gland Carcinoma at the AACR Annual Meeting 2025

CHICAGO and FORT WORTH, Texas, April 17, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”),…

8 months ago